Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
2022 · New England Journal of Medicine · 1,001 citations
https://doi.org/10.1056/nejmoa2206443
O
Oscar Alvarez
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
1.2K
Citations
3
h-index
3
i10-index
Oscar Alvarez is an academic researcher from Sant Joan de Déu Research Foundation. The author has contributed to research in topics: Psychedelics and Drug Studies & Chemical synthesis and alkaloids & Neurotransmitter Receptor Influence on Behavior. The author has an h-index of 3, co-authored 5 publications.
Papers by this author
worksSingle-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life
2023 · Journal of Affective Disorders · 150 citations
https://doi.org/10.1016/j.jad.2023.01.108
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression
2024 · Journal of Affective Disorders · 28 citations
https://doi.org/10.1016/j.jad.2024.12.061
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat